行情中心 沪深A股 上证指数 板块行情 股市异动 股圈 专题 涨跌情报站 盯盘 港股 研究所 直播 股票开户 智能选股
全球指数
数据中心 资金流向 龙虎榜 融资融券 沪深港通 比价数据 研报数据 公告掘金 新股申购 大宗交易 业绩速递 科技龙头指数

安道麦B:关于自愿披露公司涉及诉讼的进展公告(英文版)

深圳证券交易所 08-20 00:00 查看全文

Stock Code: 000553(200553) Stock abbreviation: ADAMA A(B) Announcement No.ADAMA Ltd.Announcement on Voluntary Disclosure of the Progress of

the Company’s Involvement in Litigation

The Company and all members of its board of directors hereby confirm that all

information disclosed herein is true accurate and complete with no false or misleading

statement or material omission.Special Notice:

1. Litigation Stage of the Case: Receipt of the Civil Appeal.

2. Status of the listed company as a party: ADAMA Ltd. (hereinafter referred to

as the “Company” or “ADAMA”) is one of the defendants in the first instance and

one of the appellees in the second instance.

3. Value Involved: the three appellees (China National Chemical Corporation

Limited Syngenta Group Co. Ltd. and ADAMA Ltd.) are requested to be jointly

liable for the plaintiff's investment losses of RMB 916135 and the costs of the

litigation.

4. Impact on the Company's profits and losses: Given that the second instance of

the litigation has not yet commenced as of the date of this Announcement there is

uncertainty as to the decision and thus its impact on the Company’s profits for the

current or future periods. The Company will timely fulfill its information disclosure

obligations in accordance with the law as the litigation progress.I. Basic Information on the Litigation

1In February 2025 a natural person (hereinafter referred to as the “Plaintiff”)

filed a lawsuit against China National Chemical Corporation Limited (ChemChina

Defendant I or Appellee I) Syngenta Group Co. Ltd. (Syngenta Group Defendant II

or Appellee II) and the Company (Defendant III or Appellee III) on the grounds of

liability for securities misrepresentation (hereinafter referred to as “this lawsuit”). The

Plaintiff alleged that based on the trust on the Company and its shareholders

(Defendants I and II) to fulfill their commitment and disclosure obligations he made a

long-term investment in the Company's shares. Defendants I and II failed to fulfil the

obligations set forth in the Announcement of Response to Restructuring Queries from

Shenzhen Stock Exchange Sanonda Restructuring Report and ADAMA Acquisition

Report including not resolving horizontal competition and failing to perform

obligations in accordance with the promised manner and timeline. Information

disclosed by the Company on HuDongYi the interaction platform of Shenzhen Stock

Exchange that the performance capability analysis contained in Sanonda

Restructuring Report did not constitute specific commitments made by ChemChina is

inconsistent with the committed matters constituting false and misleading statements.And the Company failed to fulfill its information disclosure obligations. The plaintiff

argued that the actions of the three defendants had a direct causal relation with his

investment losses and requested that the three defendants jointly compensate his

investment losses of RMB 916135 yuan and litigation costs.On August 4th 2025 the Intermediate People's Court of Wuhan Hubei

Province (hereinafter as “Wuhan Intermediate Court”) issued its first instance

judgment on this litigation. After reviewing the case Wuhan Intermediate Court ruled

that the plaintiff's claim lacked factual and legal basis and was not validated.Therefore the court dismissed the plaintiff's claim. The litigation costs shall be borne

by the plaintiff.

2For above information please refer to the Announcement on Voluntary

Disclosure of the Company’s Involvement in Litigation (Announcement No. 2025-5)

disclosed on February 15th 2025 and the Announcement on Voluntary Disclosure of

the Progress of the Company’s Involvement in Litigation (Announcement No.

2025-25) disclosed on August 6th 2025 at www.cninfo.com.cn.

II. Progress of the Litigation

The Company received a civil appeal recently because the plaintiff has been

dissatisfied with the Civil Judgment [(2025) E’01 No.67 of the First Instance for Civil

Case] issued by Wuhan Intermediate Court. He has filed an appeal with Hubei

Provincial Higher People's Court and requested that the first-instance judgment be

revoked the case be remanded for retrial or the judgment be amended and that the

appellees bear the litigation costs.III. Other Undisclosed Litigation and Arbitration Matters

As of the date of this announcement the Company and its subsidiaries have no

other litigation or arbitration matters that should be disclosed but have not been

disclosed.IV. Potential Impact of the Litigation on the Company's Current or Future

Profits

Given that the second instance of the litigation has not yet commenced as of the

date of this Announcement there is uncertainty as to the decision and thus its impact

on the Company’s profits for the current or future periods. While closely monitoring

the progress of the case the Company will actively take necessary measures to

safeguard the legitimate rights and interests of its own and its shareholders and

comply with laws and regulations to fulfil its information disclosure obligations in a

timely manner accordingly. The media designated by the Company for information

3disclosure are China Securities Journal Securities Times and www.cninfo.com.cn. All

information disclosed by the Company is subject to the information disclosed in the

aforementioned media. Investors are advised to make decisions with caution and pay

attention to investment risks.V. Reference Documents

1. The Civil Appeal

It is hereby announced.Board of Directors of ADAMA Ltd.August 20th 2025

4

免责声明:本页所载内容来旨在分享更多信息,不代表九方智投观点,不构成投资建议。据此操作风险自担。投资有风险、入市需谨慎。

相关股票

相关板块

  • 板块名称
  • 最新价
  • 涨跌幅

相关资讯

扫码下载

九方智投app

扫码关注

九方智投公众号

头条热搜

涨幅排行榜

  • 上证A股
  • 深证A股
  • 科创板
  • 排名
  • 股票名称
  • 最新价
  • 涨跌幅
  • 股圈